Get the Stockscreener App
28.09
1.44%
-0.41
After Hours:
28.09
Procept Biorobotics Corp stock is traded at $28.09, with a volume of 1.26M.
It is down -1.44% in the last 24 hours and down -10.34% over the past month.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
See More
Previous Close:
$28.50
Open:
$28.57
24h Volume:
1.26M
Relative Volume:
0.96
Market Cap:
$1.57B
Revenue:
$249.12M
Net Income/Loss:
$-90.19M
P/E Ratio:
-16.52
EPS:
-1.7
Net Cash Flow:
$-88.21M
1W Performance:
+2.52%
1M Performance:
-10.34%
6M Performance:
-27.23%
1Y Performance:
-57.59%
1-Day Range:
$27.62
$29.57
1-Week Range:
$26.66
$30.02
52-Week Range:
$26.66
$70.80
Procept Biorobotics Corp Stock (PRCT) Company Profile
Name
Procept Biorobotics Corp
Sector
Industry
Phone
(650) 232-9832
Address
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
28.09 | 1.59B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Initiated | UBS | Buy |
| Dec-08-25 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-09-25 | Initiated | Stephens | Overweight |
| Jul-07-25 | Initiated | Oppenheimer | Perform |
| Dec-02-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Initiated | Jefferies | Hold |
| Aug-11-23 | Initiated | Piper Sandler | Overweight |
| May-31-23 | Initiated | William Blair | Outperform |
| Oct-31-22 | Initiated | BTIG Research | Neutral |
| Oct-25-22 | Initiated | Truist | Buy |
| Sep-02-22 | Initiated | Wells Fargo | Overweight |
| Jul-15-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Goldman | Neutral |
| Oct-11-21 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | SVB Leerink | Outperform |
View All
Procept Biorobotics Corp Stock (PRCT) Latest News
Wall Street Has a Positive Opinion on PROCEPT BioRobotics (PRCT), Here's Why - Finviz
Wall Street Has a Positive Opinion on PROCEPT BioRobotics (PRCT), Here’s Why - Insider Monkey
Income Plays: Should I buy PROCEPT BioRobotics Corporation stock now2025 Market Outlook & Weekly Stock Breakout Alerts - baoquankhu1.vn
PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Unpacking a 73.66% Potential Upside - DirectorsTalk Interviews
Buyout Rumor: What hedge funds are buying PROCEPT BioRobotics CorporationJuly 2025 Volume & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
C WorldWide Group Holding A S Invests $5.35 Million in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Hits New 1-Year LowWhat's Next? - MarketBeat
Procept Biorobotics stock hits 52-week low at 27.79 USD - Investing.com
PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference - Yahoo Finance
Key Dates for Procept BioRobotics Investors - AD HOC NEWS
PROCEPT BioRobotics (PRCT) Stock Analysis: A 74% Potential Upside in the Medical Robotics Field - DirectorsTalk Interviews
After a 60% Slide, One Fund Cuts Exposure to This Healthcare Tech Stock by $12.5 Million - The Motley Fool
PROCEPT BioRobotics Corporation $PRCT Stock Position Lowered by Federated Hermes Inc. - MarketBeat
Is PROCEPT BioRobotics Corporation stock a buy or sellJuly 2025 News Drivers & Scalable Portfolio Growth Methods - mfd.ru
A Look At PROCEPT BioRobotics (PRCT) Valuation After Mixed Recent Share Price Returns - Yahoo Finance
PROCEPT BioRobotics to Report Q4 2025 Financial Results and Host Investor Day Event in February 2026 - Quiver Quantitative
PROCEPT BioRobotics® to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City - The Manila Times
Surgery robot firm PROCEPT plans Feb. 25 investor day at Nasdaq HQ - Stock Titan
Did AquaBeam Milestones and Options Activity Just Shift PROCEPT BioRobotics' (PRCT) Investment Narrative? - simplywall.st
A Look At PROCEPT BioRobotics (PRCT) Valuation As Regulatory And Clinical Catalysts Draw Investor Focus - Sahm
First Week of March 20th Options Trading For PROCEPT BioRobotics (PRCT) - InteractiveCrypto
Will PROCEPT BioRobotics Corporation benefit from current market trendsBreakout Watch & Expert-Curated Trade Recommendations - bollywoodhelpline.com
Promising growth forecasts leading to analysts’ optimism for Procept Biorobotics (PRCT) - msn.com
FMR LLC Reduces Stake in PROCEPT BioRobotics Corp by 42.10% - GuruFocus
US Market Wrap: What risks investors should watch in PROCEPT BioRobotics Corporation stock - Bộ Nội Vụ
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Assessing PROCEPT BioRobotics (PRCT) Valuation As Fresh Analyst Downgrade Meets Confident Long-Term Growth Views - simplywall.st
Peregrine Capital Management LLC Purchases Shares of 188,219 PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
Will PROCEPT BioRobotics Corporation stock outperform value stocksJuly 2025 Pullbacks & Real-Time Buy Zone Alerts - Улправда
Procept BioRobotics initiated with a buy at UBS - MSN
PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 7.1%Here's Why - MarketBeat
Is Wall Street’s Split View On PROCEPT BioRobotics (PRCT) Revealing Aquablation’s True Strategic Position? - simplywall.st
Truist Maintains Buy Rating on Procept BioRobotics (PRCT) Amid MedTech Sector Rotation - Finviz
Will PROCEPT BioRobotics Corporation stock return to pre crisis levels2025 Investor Takeaways & Capital Protection Trading Alerts - Улправда
ISRG Trading 4% Below All-Time High: Should You Buy the Stock Now? - Nasdaq
PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: A 53% Potential Upside in the Surgical Robotics Arena - DirectorsTalk Interviews
PROCEPT BioRobotics Corporation $PRCT Shares Purchased by Chicago Capital LLC - MarketBeat
PROCEPT BioRobotics Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Best Robotics Stocks To ConsiderDecember 26th - MarketBeat
How Investors Are Reacting To PROCEPT BioRobotics (PRCT) UBS Coverage Initiation And 2027 Profitability Outlook - simplywall.st
What Wall Street predicts for PROCEPT BioRobotics Corporation stock priceConsumer Goods Stocks & Free Record-Breaking Gains - Bollywood Helpline
Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) - Finviz
Promising Growth Forecasts Leading to Analysts’ Optimism for Procept Biorobotics (PRCT) - Yahoo Finance
15 Most Promising Mid-Cap Healthcare Stocks Under $50 - Insider Monkey
Procept Biorobotics Corp Stock (PRCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):